Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

Michelle M. Mielke(Mayo Clinic), Ronald C. Petersen(Mayo Clinic)

JAMA Neurology

July 26, 2021

10.1001/jamaneurol.2021.2293

Cited by 252

Related Papers

Mild cognitive impairment as a diagnostic entity

|Journal of Internal Medicine|2004|7.8k

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]

|Neurology|2001|2.1k

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

|Brain|2009|1.1k

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

|Brain|2008|956